Search alternatives:
ppm decrease » a decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
ng decrease » nn decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
10 ng » 100 ng (Expand Search), 10 mg (Expand Search), 10 nm (Expand Search)
50 n » 50 ns (Expand Search), 50 ng (Expand Search), 50 μ (Expand Search)
ppm decrease » a decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
ng decrease » nn decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
10 ng » 100 ng (Expand Search), 10 mg (Expand Search), 10 nm (Expand Search)
50 n » 50 ns (Expand Search), 50 ng (Expand Search), 50 μ (Expand Search)
-
1
-
2
-
3
Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.
Published 2023“…<p>Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.…”
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
Evaluation of disease activity for rheumatic diseases in the VTE group (n = 50).
Published 2022Subjects: -
16
-
17
Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50.
Published 2024“…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
-
18
-
19
-
20